Viewing Study NCT05891561


Ignite Creation Date: 2025-12-24 @ 12:24 PM
Ignite Modification Date: 2025-12-27 @ 9:39 PM
Study NCT ID: NCT05891561
Status: RECRUITING
Last Update Posted: 2024-11-27
First Post: 2023-05-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast Cancer
Sponsor: Shanghai Jiao Tong University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module